igf 1 lr3 log IGF-1 1mg Recombinant Human LR3 IGF-I/IGF-1 GMP

Sunders Company

Bypasses Regulation: Its design limits its affinity for IGF-binding proteins (IGFBPs), which normally restrict IGF-1's activity

The experiments on rat model RG2 and in brain-tumorized rats obtained mixed results on drug uptake and toxicity, but remarkably this combination reduced inflammation in the peri-tumoral area ( In vivo orthotopic glioblastoma-bearing rats, treatment with PTX/ETP co-loaded mPEG-PLGA NPs resulted in enhanced antitumor efficacy with significant tumor regression and a long-term survival in 40% of the animals

Finished in a practical, light-protected 50 ml tube designed to maintain the maximum stable potency of active ingredients